Naviter Wealth LLC Increases Stake in UnitedHealth Group Incorporated (NYSE:UNH)

Naviter Wealth LLC boosted its stake in UnitedHealth Group Incorporated (NYSE:UNH) by 15.8% during the first quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The firm owned 7,095 shares of the healthcare conglomerate’s stock after purchasing an additional 968 shares during the period. Naviter Wealth LLC’s holdings in UnitedHealth Group were worth $3,510,000 at the end of the most recent reporting period.

A number of other large investors have also bought and sold shares of UNH. Richelieu Gestion SA purchased a new position in shares of UnitedHealth Group during the fourth quarter valued at approximately $26,000. CGC Financial Services LLC grew its stake in UnitedHealth Group by 1,000.0% in the fourth quarter. CGC Financial Services LLC now owns 55 shares of the healthcare conglomerate’s stock worth $29,000 after purchasing an additional 50 shares during the period. True Wealth Design LLC purchased a new stake in UnitedHealth Group in the fourth quarter worth $31,000. LFA Lugano Financial Advisors SA grew its stake in UnitedHealth Group by 148.1% in the fourth quarter. LFA Lugano Financial Advisors SA now owns 67 shares of the healthcare conglomerate’s stock worth $35,000 after purchasing an additional 40 shares during the period. Finally, Transcendent Capital Group LLC purchased a new stake in UnitedHealth Group in the fourth quarter worth $40,000. 87.86% of the stock is owned by hedge funds and other institutional investors.

UnitedHealth Group Stock Performance

Shares of UNH opened at $498.13 on Wednesday. The company has a quick ratio of 0.85, a current ratio of 0.85 and a debt-to-equity ratio of 0.69. The business has a 50-day simple moving average of $498.40 and a two-hundred day simple moving average of $501.35. The stock has a market cap of $458.47 billion, a price-to-earnings ratio of 30.45, a PEG ratio of 1.48 and a beta of 0.60. UnitedHealth Group Incorporated has a 52 week low of $436.38 and a 52 week high of $554.70.

UnitedHealth Group (NYSE:UNH) last issued its quarterly earnings results on Tuesday, April 16th. The healthcare conglomerate reported $6.91 EPS for the quarter, topping analysts’ consensus estimates of $6.63 by $0.28. The business had revenue of $99.80 billion during the quarter, compared to analysts’ expectations of $99.23 billion. UnitedHealth Group had a return on equity of 26.50% and a net margin of 4.05%. The business’s quarterly revenue was up 8.6% on a year-over-year basis. During the same quarter in the prior year, the business posted $6.26 earnings per share. On average, analysts expect that UnitedHealth Group Incorporated will post 27.55 EPS for the current year.

UnitedHealth Group Increases Dividend

The firm also recently announced a quarterly dividend, which was paid on Tuesday, June 25th. Investors of record on Monday, June 17th were given a dividend of $2.10 per share. The ex-dividend date of this dividend was Monday, June 17th. This represents a $8.40 annualized dividend and a dividend yield of 1.69%. This is a boost from UnitedHealth Group’s previous quarterly dividend of $1.88. UnitedHealth Group’s dividend payout ratio (DPR) is currently 51.34%.

Analyst Upgrades and Downgrades

UNH has been the topic of several recent research reports. Baird R W raised UnitedHealth Group to a “strong-buy” rating in a research note on Thursday, May 30th. Barclays boosted their target price on UnitedHealth Group from $534.00 to $560.00 and gave the stock an “overweight” rating in a report on Wednesday, April 17th. JPMorgan Chase & Co. boosted their target price on UnitedHealth Group from $546.00 to $559.00 and gave the stock an “overweight” rating in a report on Thursday, May 30th. Deutsche Bank Aktiengesellschaft boosted their target price on UnitedHealth Group from $545.00 to $562.00 and gave the stock a “buy” rating in a report on Friday, April 19th. Finally, StockNews.com downgraded UnitedHealth Group from a “buy” rating to a “hold” rating in a report on Friday, June 28th. Three equities research analysts have rated the stock with a hold rating, seventeen have given a buy rating and one has assigned a strong buy rating to the stock. Based on data from MarketBeat.com, UnitedHealth Group currently has a consensus rating of “Moderate Buy” and a consensus target price of $579.74.

UnitedHealth Group Profile

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.